Medication info
Itorin Tablet 10/10

Itorin Tablet 10/10

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
White to light yellow, bi-convex rectangular tablet
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201601703 · Approved 2016.03.31 · Insurance code 671806050

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less reduction in LDL cholesterol may start with 10/10mg daily. After starting treatment with this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or more. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section on patients with abnormal liver function under 5. General Precautions in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. If higher doses of this medicine are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular diseases due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication helps reduce total cholesterol, LDL cholesterol, ApoB protein, and triglycerides while increasing HDL cholesterol in patients with primary hypercholesterolemia and mixed hyperlipidemia in conjunction with dietary therapy. It can also be used as an adjunctive or alternative treatment for patients with homozygous familial hypercholesterolemia. This drug is effective when combined with lipid-regulating medications and when non-drug treatments do not respond. Before administration, secondary causes, such as diabetes and hypothyroidism, should be identified and may require treatment. During treatment, total cholesterol, LDL, HDL, and triglyceride levels should be measured periodically for management. This medication is used to reduce the risk of atherosclerotic vascular disease due to hypercholesterolemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less reduction in LDL cholesterol may start with 10/10mg daily. After starting treatment with this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or more. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section on patients with abnormal liver function under 5. General Precautions in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. If higher doses of this medicine are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Precautions

This medication is primarily used to lower blood cholesterol levels. However, care should be taken as muscle-related issues may arise while taking this medication. In particular, muscle pain or weakness may occur, and in severe cases, a condition called rhabdomyolysis may develop, so if these symptoms appear, inform your doctor immediately. This medication can affect liver function, and patients with liver disease or abnormally high liver enzyme levels should not take it. Pregnant or nursing women should not take this medication, and women who could become pregnant should consult a doctor before taking it. Additionally, taking this medication with certain other drugs may increase the risk of muscle damage, so be sure to inform healthcare professionals if you are taking other medications. Older adults or patients with impaired kidney function also require more careful management when taking this medication. Regular blood tests to check liver enzymes and muscle damage markers during treatment are recommended. If you experience unexplained muscle pain, tenderness, or weakness while taking this medication, consult your healthcare provider immediately. This medication is also not suitable for patients with certain genetic lactase deficiency, so those with the condition should avoid taking it. Finally, caution should be taken with the consumption of specific foods such as grapefruit juice while taking this medication, and consulting with a physician or pharmacist is important.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory tract infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, increased liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, paresthesia, depression, cholelithiasis, cholecystitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia, generalized drug reaction with systemic symptoms, polymorphous erythema, drug-induced liver injury, myasthenia, cataract, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, dysgeusia, oculomotor dysfunction, facial paresis, tremor, peripheral neuropathy, peripheral nerve palsy, mental disorders, anxiety, sleep disturbances, insomnia, nightmares, cognitive impairment, severe myasthenia gravis, oculobulbar myasthenia, interstitial lung disease, lupus-like erythematosus syndrome, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibodies, increased erythrocyte sedimentation rate, arthritis, fever, chills, flush, malaise, dyspnea, cholestatic jaundice, hepatic steatosis, cirrhosis, fulminant hepatic necrosis, liver cancer, liver failure, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, sexual dysfunction, ophthalmoplegia, anemia, elevated aminotransferases, elevated ALP, elevated gamma-GT, increased bilirubin levels, thyroid dysfunction, elevated serum creatine kinase, transient liver function test abnormalities, increased HbA1c, elevated fasting blood glucose levels, edema, thirst, facial edema, syncope, insomnia, gastritis, atrophic gastritis, mucus stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is also advisable to store it at room temperature, between 1 to 30 degrees Celsius, avoiding extreme temperatures.

Appearance and packaging

Appearance

White to light yellow, bi-convex rectangular tablet

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.